Nu Skin Q3 swings to net loss of $742,000; revenue falls 15% to $311 million
NUS•Nu Skin Enterprises reported a third-quarter 2026 net loss of $742,000, or $0.02 per share, as revenue fell 15% year over year to $311.01 million. It forecast fourth-quarter revenue of $310 million to $340 million and earnings per share of $0.05 to $0.15.
1. Quarterly results
Nu Skin Enterprises swung to a third-quarter 2026 loss of $0.02 per share from a year-earlier profit. Revenue declined 15% year over year to $311.01 million, and customers fell 18% to 609,469.
2. Outlook and products
For the fourth quarter, the company projected revenue of $310 million to $340 million and earnings per share of $0.05 to $0.15. Management reported continued adoption of Prysm iO and year-to-date revenue growth for LifePak nutritional supplements.
